Tirzepatide is our most successful product. Our scientists have found the most success with combined, dual-acting appetite-suppressing properties. This product will change your life!

Tirzepatide has a dual approach with both GLP and GIP benefits. A dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of these incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying. This multifaceted approach helps improve blood sugar control, promotes weight loss, and reduces the risk of cardiovascular events in diabetic patients. Tirzepatide has shown promising results in clinical trials, offering a new therapeutic option for those struggling to achieve glycemic control with existing treatments.

Ingredients:
Tirzepatide 2.5mg vial x 4 weeks $119
Tirzepatide 5mg Vial x 4 weeks $199
Tirzepatide 7.5mg vial x 4weeks $299
Tirzepatide 10mg vial x 4 weeks $349
Tirzepatide 12.5mg vial x 4 weeks $399
Tirzepatide 15mg Vial x 4weeks $499

Request payment link for other sizes

Semaglutide-Cyanocobalamin is our premium customized formulation of the GLP-1 receptor agonist Semaglutide, designed to meet the specific needs of scientists requiring precise dosages. It is available in various strengths (5 mg, 10 mg, 15 mg, and 20 mg), offering flexibility to tailor experimental interventions for diabetes and weight management.

Semaglutide mimics the action of GLP-1, a hormone that helps regulate blood sugar levels and appetite. It stimulates insulin secretion in response to elevated blood sugar levels. It reduces glucagon release, which lowers glucose production by the liver and slows gastric emptying, increasing feelings of fullness and reducing food intake.